---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020309"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2023-06-06T23:59:59+00:00"
generated_at: "2026-06-14T07:03:52.177054+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical raises $1.5M via registered direct offering of 701,756 shares at $2.1375 each

## Summary
- Gross proceeds of $1.5M from sale of 701,756 shares of common stock at $2.1375/share.
- Concurrent private placement: Series C warrants to purchase up to 350,878 shares at $2.075, exercisable for 5.5 years.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee plus warrants for 35,088 shares.
- Net proceeds to fund development and commercialization of LIBERTY Robotic System and working capital.
- Offering closed on June 6, 2023 under shelf registration statement (File No. 333-250966).

## SEC filing metadata
- accession: 0001493152-23-020309
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2023-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020309
- JSON: https://secwatch.observer/filing/0001493152-23-020309.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020309.txt

## Key facts
- Material Agreements
  Microbot Medical Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2023-05-16).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: H.C. Wainwright & Co., LLC
  - Effective: 2023-05-16
  source text: On May 16, 2023 and in connection with the Offerings, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright agreed to serve as the exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm
- Material Agreements
  Microbot Medical Inc. entered into Purchase Agreements with institutional investors valued at approximately $1.5 million (effective 2023-06-02).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investors
  - Value: approximately $1.5 million
  - Effective: 2023-06-02
  source text: On June 2, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into Securities Purchase Agreements (the “Purchase Agreements”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), an aggregate of 701,756 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $2.1375 per share, for aggregate gross proceeds from the Offerings (as defined below) of approximately $1.5 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223020309/0001493152-23-020309-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.